IXAZOMIB, LENALIDOMIDE, AND DEXAMETHASONE FOR RELAPSED MULTIPLE MYELOMA: AN EARLY SINGLE CENTER EXPERIENCE IN RUSSIA

被引：0
|
作者：
Luchinin, A. [1 ]
Semochkin, S. [2 ]
Minaeva, N. [1 ]
Samarina, S. [1 ]
机构：
[1] Med Biol Agcy, Kirov Sci Res Inst Hematol & Blood Transfus, Kirov, Russia
[2] Pirogov Russian Natl Res Med Univ, Moscow, Russia
来源：
HAEMATOLOGICA | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P59
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [1] BUDGET IMPACT OF IXAZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN RUSSIA
    Pyadushkina, E.
    Derkach, E., V
    Boyarskaya, T.
    [J]. VALUE IN HEALTH, 2018, 21 : S26 - S26
  • [2] Real World Use of Ixazomib With Lenalidomide and Dexamethasone for Patients With Relapsed Multiple Myeloma
    Lawson, Gabrielle
    Ziff, Monica
    De-Silva, Dunnya
    Cheesman, Simon
    Kyriakou, Charalampia
    Mehta, Atul
    Mahmood, Shameem
    Papanikolaou, Xenofon
    Rabin, Neil
    Sachchithanantham, Sajitha
    Sive, Jonathan
    Wechalekar, Ashutosh
    Yong, Kwee
    Popat, Rakesh
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E264 - E264
  • [3] Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Moreau, P.
    Masszi, T.
    Grzasko, N.
    Bahlis, N. J.
    Hansson, M.
    Pour, L.
    Sandhu, I.
    Ganly, P.
    Baker, B. W.
    Jackson, S. R.
    Stoppa, A. -M.
    Simpson, D. R.
    Gimsing, P.
    Palumbo, A.
    Garderet, L.
    Cavo, M.
    Kumar, S.
    Touzeau, C.
    Buadi, F. K.
    Laubach, J. P.
    Berg, D. T.
    Lin, J.
    Di Bacco, A.
    Hui, A. -M.
    van de Velde, H.
    Richardson, P. G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (17): : 1621 - 1634
  • [4] Real-world comparison of Ixazomib, lenalidomide and dexamethasone vs lenalidomide and dexamethasone in relapsed and refractory multiple myeloma
    Minarik, Jiri
    Pika, Tomas
    Radocha, Jakub
    Jungova, Alexandra
    Straub, Jan
    Jelinek, Tomas
    Pour, Ludek
    Pavlicek, Petr
    Mistrik, Martin
    Brozova, Lucie
    Krhovska, Petra
    Machalkova, Katerina
    Jindra, Pavel
    Spicka, Ivan
    Plonkova, Hana
    Stork, Martin
    Bacovsky, Jaroslav
    Capkova, Lenka
    Sykora, Michal
    Kessler, Petr
    Stejskal, Lukas
    Heindorfer, Adriana
    Ullrychova, Jana
    Maisnar, Vladimir
    Hajek, Roman
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E271 - E272
  • [5] REAL WORLD USE OF IXAZOMIB WITH LENALIDOMIDE AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED AND RELAPSED REFRACTORY MULTIPLE MYELOMA
    Ziff, M.
    Cheesman, S.
    Kyriakou, C.
    Mehta, A.
    Papanikolaou, X.
    Rabin, N.
    Wechalekar, A.
    Yong, K.
    Popat, R.
    [J]. HAEMATOLOGICA, 2017, 102 : 786 - 787
  • [6] BENDAMUSTINE, LENALIDOMIDE AND DEXAMETHASONE (BLD) COMBINATION THERAPY IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE
    Ciuffreda, L.
    Diomede, D.
    Miccolis, R. M.
    De Santis, G.
    Buquicchio, C.
    Santeramo, T. M.
    Tarantini, G.
    [J]. HAEMATOLOGICA, 2016, 101 : 796 - 797
  • [7] BUDGET IMPACT OF IXAZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN BRAZIL
    Sakagute, M.
    Tanaka, P. Y.
    Duva, A.
    Rigolon, J.
    [J]. VALUE IN HEALTH, 2019, 22 : S459 - S459
  • [8] Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma
    Kumar, Shaji
    Moreau, Philippe
    Hari, Parameswaran
    Mateos, Maria-Victoria
    Ludwig, Heinz
    Shustik, Chaim
    Masszi, Tamas
    Spencer, Andrew
    Hajek, Roman
    Romeril, Kenneth
    Avivi, Irit
    Liberati, Anna M.
    Minnema, Monique C.
    Einsele, Hermann
    Lonial, Sagar
    Berg, Deborah
    Lin, Jianchang
    Gupta, Neeraj
    Esseltine, Dixie-Lee
    Richardson, Paul G.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (04) : 571 - 582
  • [9] Network meta-analysis of efficacy of ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma
    DerSarkissian, Maral
    Cranmer, Holly
    Dabora, Jonathan
    Bocharova, Iryna
    Cherepanov, Dasha
    Cheng, Mu
    Bhak, Rachel H.
    Duh, Mei Sheng
    [J]. HEMATOLOGY, 2023, 28 (01)
  • [10] Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma
    Hajek, Roman
    Minarik, Jiri
    Straub, Jan
    Pour, Ludek
    Jungova, Alexandra
    Berdeja, Jesus G.
    Boccadoro, Mario
    Brozova, Lucie
    Spencer, Andrew
    Rhee, Frits van
    Vela-Ojeda, Jorge
    Thompson, Michael A.
    Abonour, Rafat
    Chari, Ajai
    Cook, Gordon
    Costello, Caitlin L.
    Davies, Faith E.
    Hungria, Vania T. M.
    Lee, Hans C.
    Leleu, Xavier
    Puig, Noemi
    Rifkin, Robert M.
    Terpos, Evangelos
    Usmani, Saad Z.
    Weisel, Katja C.
    Zonder, Jeffrey A.
    Barinova, Magda
    Kuhn, Matyas
    Silar, Jiri
    Capkova, Lenka
    Galvez, Kenny
    Lu, Jin
    Elliott, Jennifer
    Stull, Dawn Marie
    Ren, Kaili
    Maisnar, Vladimir
    [J]. FUTURE ONCOLOGY, 2021, 17 (19) : 2499 - 2512
12345